Ascendis Pharma A/S
SWB:A71
Ascendis Pharma A/S
SWB:A71
Price:
188
EUR
-1.57%
Market Closed
Market Cap:
€10.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Ascendis Pharma A/S
SWB:A71
|
DK |
|
A
|
Atoss Software AG
XBER:AOF
|
DE |
|
J
|
J M Smucker Co
F:JM2
|
US |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
Kite Realty Group Trust
F:FGC1
|
US |
|
Komercni Banka as
LSE:0IKH
|
CZ |
|
W
|
Westpac Banking Corp
XBER:WBC
|
AU |
|
Daito Trust Construction Co Ltd
OTC:DITTF
|
JP |
|
I
|
Intesa Sanpaolo SpA
XBER:IES
|
IT |
|
J
|
Jefferies Financial Group Inc
DUS:LN3
|
US |
|
Seatrium Limited
F:S8N0
|
SG |
|
R
|
RPC Inc
F:RLD
|
US |
|
NOA Lithium Brines Inc
F:N7N
|
CA |
|
Ekopak NV
F:7XZ
|
BE |
|
P
|
Parker-Hannifin Corp
XBER:PAR
|
US |
|
Sprint Bioscience AB
F:5JA1
|
SE |
|
W
|
Winnebago Industries Inc
F:WI1
|
US |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
Ascendis Pharma A/S
Wall Street analysts forecast A71 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for A71 is 250.67 EUR with a low forecast of 215.53 EUR and a high forecast of 300.51 EUR.
Lowest Forecast
Price Target
215.53
EUR
15% Upside
Average Forecast
Price Target
250.67
EUR
33% Upside
Highest Forecast
Price Target
300.51
EUR
60% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
250.67
EUR
250.67
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 250.67 EUR with a low forecast of 215.53 EUR and a high forecast of 300.51 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
23%
23%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 23%.
